BRCA1 deficiency increases sensitivity of ovarian cancer cells to auranofin
An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.
Jan 8, 2016
0
13